For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition ...

Multiple myeloma can relapse two or more times, and tends to become more aggressive and more treatment-resistant with each ...

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. The U.S. Food and ...

Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients ...

A new option is now approved to treat adults living with high-risk smoldering multiple myeloma. 1 The FDA has greenlit ...

MM often goes undetected until its later stages because it presents with non-specific symptoms, including fatigue, weight loss, bone pain, and recurrent infections. 2,3 However, better awareness, ...

Lee May, diagnosed with aggressive multiple myeloma at 59, defied odds with cutting-edge treatments at UCSF Health, including ...

Black survivors of multiple myeloma say the latest developments in treatment give them hope even as federal research cuts ...

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

Multiple myeloma survivor Ronald D. Chin, one of CURE’s contributing bloggers, shared a bit of his blood cancer journey in a ...

In patients with symptomatic multiple myeloma, renal impairment leading to acute kidney injury (AKI) is a common complication ...

WASHINGTON -- House Majority Leader Steve Scalise has been diagnosed with "a very treatable blood cancer," and has started treatment, he announced on Tuesday. "After a few days of not feeling like ...